FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Acquired a data company and sharply increased its clinical-trial orders. Also seen: M&A · integration

  • Reported nine-month new orders above KRW 75 billion and operating profit of KRW 4.5 billion. Source
  • Acquired a medical-data company. Source

Roles often seen at this stageClinical & PV · Data & AI · BD & licensing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

C&R Research

A Korean contract research organisation that is widening into clinical data services after acquiring a data company.

Clinical trial services

Service

Contract clinical-trial services in Korea and abroad, with regulatory support through its US office.

Completion reported

Acquired the medical-data company Mediplexus.

Completion reported

Reported that new orders for the first nine months exceeded KRW 75 billion.

Official role guide

C&R Research careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 씨엔알리서치, 3분기 누적 영업익 45억 ↗라포르시안 · Published 2026-11-13 · Sources checked 2026-11-15 · Original unavailable
  2. 씨엔알리서치, 메디플렉서스 인수…'데이터 CRO' 본격화 ↗비즈워치 · Published 2026-01-08 · Sources checked 2026-11-15 · Original unavailable